IRF6 and Ascites: In contrast, all treatment groups exhibited significant reductions in the incidence of abdominal wall tumors, ascites formation, and severity of peritoneal adhesions, with the P407-DOX-SSD-Lps group demonstrating the most pronounced therapeutic effects (Tables S5 and S6).